Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care

Recruiting now · Not applicable

Conditions studied: Diabetic Retinopathy

In brief

This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the interpretation of fundus photographs obtained by trained nursing assistant using a portable fundus camera in a primary care setting, compared with images obtained by the same method, but interpreted by ophthalmologists.

Key facts

Study ID

NCT07236879

Run by

Hospital de Clinicas de Porto Alegre

People needed

922

Starts

2024-08-08

Expected to finish

2026-12-01

Last updated by the study team

2025-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (> 18 years old) diagnosed with diabetes mellitus who agree to participate in the study.

You may not qualify if…

• Any contraindication for pharmacological mydriasis (such as knowledge of having closed-angle glaucoma, pregnancy).
• Life expectancy less than 6 months

Where it is running

• Hospital de Clínicas de Porto Alegre — Porto Alegre, Rio Grande do Sul, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.